Tag Archives: Dr Oystein Fluge

Norwegian Rituximab studies update

Posted on 11/03/2017 by wames

Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) ​RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab studies update

Metabolic switch may bring on CFS

Posted on 02/14/2017 by wames

New Scientist article, by Andy Coghlan, 13 February 2016: Metabolic switch may bring on chronic fatigue syndrome It’s as if a switch has been flicked. Evidence is mounting that chronic fatigue syndrome (CFS) is caused by the body swapping to … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Metabolic switch may bring on CFS

Video lectures from English & Norwegian researchers in Norwich

Posted on 02/10/2017 by wames

Invest in ME public talks in Norwich on ME/CFS biomedical research, published 7 Feb 2017 An event held in Norwich in January 2017 gave the public a chance to hear about some of the biomedical research being undertaken on the … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Video lectures from English & Norwegian researchers in Norwich

Discussion of Fluge’s finding of key metabolic enzyme impairment in ME/CFS

Posted on 01/18/2017 by wames

TV2 interview with Dr Øystein Fluge on his latest research on ME/CFS – in Norwegian with English subtitles. Begins with a man who is very severely affected by ME. (11 minutes 23 seconds)    Watch video   Medscape Medical news article, 13 January 2017: … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on Discussion of Fluge’s finding of key metabolic enzyme impairment in ME/CFS

Fuel shortage: Norwegian study expands on energy problem in ME/CFS

Posted on 01/09/2017 by wames

Health rising blog post, by Cort Johnson, 27 Dec 2016: Fuel shortage: Norwegian study Expands on Energy Problem in Chronic Fatigue Syndrome (ME/CFS) Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Fuel shortage: Norwegian study expands on energy problem in ME/CFS

Metabolic profiling indicates impaired pyruvate dehydrogenase function in ME/CFS

Posted on 12/23/2016 by wames

Research abstract: Myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is a debilitating disease of unknown etiology, with hallmark symptoms including postexertional malaise and poor recovery. Metabolic dysfunction is a plausible contributing factor. We hypothesized that changes in serum amino acids may disclose … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Metabolic profiling indicates impaired pyruvate dehydrogenase function in ME/CFS

The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Posted on 12/16/2016 by wames

Video posted on the RME Sverige You Tube channel, 19 Nov 2016: The RituxME and CycloME studies – Ongoing Clinical Research in the ME/CFS Research Group, by Öystein Fluge, MD, Dep. Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norge … Continue reading →

Posted in News | Tagged , , , , | Comments Off on The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Mella finds hypometabolic state in ME/CFS

Posted on 10/17/2016 by wames

Health rising blog post, by Cort Johnson, 15 October 2016: Another Hypometabolic Signature Found Fluge and Mella are best known for their Rituximab work, but just last week Mella reported that they’d found a hypometabolic state in ME/CFS as well. … Continue reading →

Posted in News | Tagged , , , , , , , , , | Comments Off on Mella finds hypometabolic state in ME/CFS

New rituximab trial results from Norway

Posted on 08/22/2016 by wames

Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on New rituximab trial results from Norway

Cancer doctor Dagfinn Øgreid has treated ME patients with rituximab

Posted on 11/26/2015 by wames

Blog article: Offers private ME treatment with cancer drugs – scientists react, by Anne Grete Storvik, Nov 23 2015 in Dagensmedicin [ translated by Google translate] A private clinic in Sandnes offers treatment for ME with the cancer drug rituximab. Patients pay … Continue reading →

Posted in News | Tagged , , , , , , | 1 Comment